Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression. - Wikidata - awgldk - TriplyDB

Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression.

Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression.

http://www.wikidata.org/entity/Q35169193

about

FLRG, a new ADAM12-associated protein, modulates osteoclast differentiation Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actin-green fluorescent protein.Osteoimmunology: interactions of the bone and immune system Human primary osteoclasts: in vitro generation and applications as pharmacological and clinical assay Nuclear receptors in bone physiology and diseases Mechanisms of bone anabolism regulated by statins Disorders of bone remodeling From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation.Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators.Minireview: osteoprotective action of estrogens is mediated by osteoclastic estrogen receptor-alpha Estrogen action on bone marrow osteoclast lineage cells of postmenopausal women in vivo.The oxytocin-bone axis Physiology of bone loss.The mechanisms of estrogen regulation of bone resorption.Receptor activator of nuclear factor-kappaB ligand and osteoprotegerin: potential implications for the pathogenesis and treatment of malignant bone diseases.TNFRSF11A and TNFSF11 are associated with age at menarche and natural menopause in white women.Female reproductive system and bone.A potent analog of 1alpha,25-dihydroxyvitamin D3 selectively induces bone formation.c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs Prevention and treatment of postmenopausal osteoporosis.Characterization of functional reprogramming during osteoclast development using quantitative proteomics and mRNA profiling.Oxytocin and bone IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1.Deer antlers: a zoological curiosity or the key to understanding organ regeneration in mammals?Dual Effect of Chrysanthemum indicum Extract to Stimulate Osteoblast Differentiation and Inhibit Osteoclast Formation and Resorption In Vitro Bone mass regulation of leptin and postmenopausal osteoporosis with obesity.Role of RANK ligand in mediating increased bone resorption in early postmenopausal women Targeted deletion of histidine decarboxylase gene in mice increases bone formation and protects against ovariectomy-induced bone loss Minireview: nuclear receptor regulation of osteoclast and bone remodeling.Japanese medaka: a non-mammalian vertebrate model for studying sex and age-related bone metabolism in vivo.Zoledronic acid (Zometa) use in bone disease.Prolactin and estrogen enhance the activity of activating protein 1 in breast cancer cells: role of extracellularly regulated kinase 1/2-mediated signals to c-fos Exploring the mechanisms regulating regeneration of deer antlers The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed?Suppressive function of androgen receptor in bone resorption Increased bone mass in mice after single injection of anti-receptor activator of nuclear factor-kappaB ligand-neutralizing antibody: evidence for bone anabolic effect of parathyroid hormone in mice with few osteoclasts Conditional inactivation of noggin in the postnatal skeleton causes osteopenia

P2860

Q24318438-4D04E3ED-9963-4A26-9A00-D9B00B2371A5 Q24550787-8C380412-EC1C-4C56-AFE4-0C39A4ABB468 Q24655113-B3FEDE2A-10CB-4E17-ABCC-489E3CEFA2D9 Q24806517-63D08AF9-088D-4566-8028-2F9983955548 Q26853017-3D57CB64-1310-4A22-92E3-A4E402E7413E Q26992028-43C7C3A8-F3E6-4A42-8EC3-D1060156FD0B Q28295303-971D61F1-4F2C-4987-9601-B113E8732057 Q28385120-DD589FBF-8FCD-4BAA-B370-A1B9CEF3AC13 Q28393372-696F83F9-12C8-4DE1-8C0F-A16760346513 Q28590415-D46AB038-069C-442A-8AD2-DD0941ECCA32 Q31717820-B6D9B665-1B5E-4BEC-985F-9143A0F025BD Q33576459-12E8FC09-51B0-4FA4-AAC1-95B7F9691987 Q33637546-948CD97D-A306-4892-92EB-4DCB98EAA67E Q33742652-2737AB3B-5DEB-4D59-9705-FBF8DA31F689 Q33940480-599730F7-F0F0-4219-9B28-4829AFC0F6FD Q33980978-3EB36000-CA1E-4273-AFCC-1EAB80723C34 Q34086515-08B3F370-260E-4C00-89BC-091722652DEB Q34086847-2F9A8349-3036-4853-8A44-B54768EAD61A Q34126306-5A7FE559-52B8-4A13-AA6E-B2A64138565B Q34142868-20B0985A-B44D-4248-B727-05A8D612BDBC Q34159735-A0C7183D-F1B4-49B2-9FCB-115842507879 Q34264017-B225303E-F4DE-4C8C-A2B0-2C44202E5CCE Q34296614-F1EFDFBE-A653-4245-8E93-0064FB606796 Q34303394-DF8D8E09-352A-4104-BBBE-2ADB2DE1A463 Q34356431-5B1941E0-210A-42D3-A1C2-F740350FED87 Q34465312-3D373E2B-96E9-4850-B8C9-A8D31331040A Q34470814-4DC87414-023E-4245-A35E-46B5A4A8DE8B Q34495848-27768DDD-ED40-4FF5-8632-1BC8213D0F1D Q34536487-E4FF34E1-3050-4596-8337-0F7440972BAA Q34912769-5EDCEEDC-D786-4AFE-B822-C3CA27427C96 Q35022687-DFD2C53F-07F4-4A4E-85C1-DF863AA245E3 Q35054970-56A43497-78CA-4E9B-A0A9-C764C4D27982 Q35093569-75F8BB60-F884-4850-B4BB-E2825DCDA5AF Q35117725-6276DC64-B9F2-436D-8CFD-0B55E32D2A4D Q35121907-6B19B4AB-99DC-42A6-84EB-606F8F271516 Q35213959-14088B8D-1D59-45B5-8C38-C88E9274654F Q35229894-630A5C80-F443-4AE7-835A-0E317574F6CA Q35234694-81A6458A-849F-4DB6-8671-BE07D5C7BB4C Q35378487-B01D7539-7F09-4523-BBD1-40B98191693D Q35872773-5B800383-96A6-41F3-8A7C-15B3B8F350A3

P2860

Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression.

http://www.wikidata.org/entity/Q35169193

description

2000 nî lūn-bûn

@nan

2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Estrogens suppress RANK ligand ...... sm involving c-Jun repression.

@ast

Estrogens suppress RANK ligand ...... sm involving c-Jun repression.

@en

type

label

Estrogens suppress RANK ligand ...... sm involving c-Jun repression.

@ast

Estrogens suppress RANK ligand ...... sm involving c-Jun repression.

@en

prefLabel

Estrogens suppress RANK ligand ...... sm involving c-Jun repression.

@ast

Estrogens suppress RANK ligand ...... sm involving c-Jun repression.

@en

P1433

Q35169193-9E6F394E-FDB4-4F37-9F5C-8078C9D3F7D0

P1476

Q35169193-B8B86669-E90A-4022-8A51-D4E258213688

P2093

Q35169193-4B6710B5-6FA4-4477-8BFB-7575F216045F

Q35169193-4F9525C8-312A-4AC5-B1D6-B697719B6F06

Q35169193-53913B77-8B10-4527-AA69-2E9B9C820210

Q35169193-B3E361FD-EF2F-49F5-B505-0031DD425CC2

P2860

Q35169193-01CD1D08-C487-44A8-889B-97A15D12AECE

Q35169193-0A7B456F-5010-4350-878C-FC310A442D0C

Q35169193-0E422DD2-C570-4DE9-84AF-BBC8B6B07758

Q35169193-0E516F7E-B2AE-455D-BDD5-6342616A8334

Q35169193-167B9D22-826C-40FE-B82C-1FF3E38E9C73

Q35169193-17A52244-9B02-4DCC-A742-57B8E4CEC820

Q35169193-1BB21950-E092-4306-9849-F525136F95A8

Q35169193-22112D35-A20A-446D-89FD-C01957FD5FB7

Q35169193-2A844A18-DBE6-4B78-83C9-D16840B04821

Q35169193-2B827D47-4E8C-4FF1-8415-A80CD1091581

P304

Q35169193-EF002BAF-06A7-47E2-9D63-48C42816A711

P31

Q35169193-83E55892-C0AA-4294-A3B8-3B879FF516EE

P356

Q35169193-6628E32A-D04B-4AFF-951B-E8CB33916AF3

P407

Q35169193-ECA5530C-1C52-46AC-BEF3-A9A5C89599F5

P433

Q35169193-1C9BC702-CA00-4636-9B2B-78A8C44CCB3F

P478

Q35169193-1F3C89F1-653D-4DEE-97AB-3C958237C745

P577

Q35169193-E584C3E0-E4C9-4B08-B3A2-6B0F2B286103

P5875

Q35169193-CEE069BB-FD93-4331-8BC5-E3FAE0FAD4EA

P698

Q35169193-7C8AFCFB-5A50-4C75-9C50-63487690A9B1

P932

Q35169193-D3694538-DA3D-4476-B857-F4A1EA50ECDA

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Estrogens suppress RANK ligand ...... sm involving c-Jun repression.

@en

P2093

A C Bendixen

http://www.w3.org/2001/XMLSchema#string

J W Pike

http://www.w3.org/2001/XMLSchema#string

K M Dienger

http://www.w3.org/2001/XMLSchema#string

N K Shevde

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Molecular basis of agonism and antagonism in the oestrogen receptor

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

Estrogen receptor null mice: what have we learned and where will they lead us?

Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase

P304

7829-7834

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.130200197

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P577

2000-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12450271

http://www.w3.org/2001/XMLSchema#string

P698

10869427

http://www.w3.org/2001/XMLSchema#string

P932

16630

http://www.w3.org/2001/XMLSchema#string